1. CurriculumVitae KatrijnMichielsen
C O N T A C T A N D P E R S O N A L I N F O R M A T I ON
NAME KatrijnMichielsen
DATE OF BIRTH 06/03/1986
PLACE OF BIRTH Turnhout,Belgium
NATIONALITY Belgian
MARITAL STATUS legal cohabitant
RESIDENCY Diestsesteenweg207
3300 Tienen
Belgium
CURRENTWORKPLACE Departmentof Imaging&Pathology
Medical ImagingResearchCenter(MIRC)
UniversityHospitalsLeuven
Herestraat 49
3000 Leuven
Belgium
MOBILE +32 (0)497/67 88 14
E-MAIL katrijn.michielsen1986@gmail.com
E D U C A T I O N
1992-1997 ElementarySchool Sint-Victor, Turnhout
1997-2004 SecondaryEducation, optionSciences-Mathematics(8hr), Sint-Victor,Turnhout
2004-2008 BachelorinBiomedical Sciences(withdistinction), KULeuven
2008-2010 Master inBiomedical Sciences,GraduatingoptionResearch,Managementand
CommunicationinBiomedical Sciences,MinorManagementandcommunication,withgreat
distinction,KULeuven
Thesis:“The role of MRI inprenatal care”
Promoter: Prof. Dr. StevenDymarkowski
Co-promoter: Prof. Dr. FilipClaus
2010-2016 PhDin Biomedical Sciences,UniversityHospitalsLeuven
Thesistitle:“The role of whole bodydiffusion-weightedMRIinovariancancer”
(Publicdefense:Fri 24th
June 2016
Promoter: Prof. Dr. VincentVandecaveye
Co-promoters: Prof. Dr. StevenDymarkowski
Prof. Dr. I. Vergote

2. CurriculumVitae KatrijnMichielsen
A D D I T I O N A L T R A I N I N G P R O G R A M S
2006 FirstAid& Emergencytreatmentforinjury,KULeuven
2006 LaboratoryAnimal Science,KULeuven
2007 Patientcare andmedical-technicalskills, KULeuven
2008-2009 Postacademiceducation;MultidisciplinarForensicSciences,KULeuven
Thesis:“The role of dactyloscopyinforensicexpertise”
Promotor:Prof.Dr. WimVan de Voorde
2009-2010 AdvancedMedical Imaging,HotTopicsI& II inMedical Imaging,KULeuven
2010-2011 Postgraduate StudiesinAdvancedMedical Imaging,KULeuven
Thesis:“Pre-treatmentDCE-MRIforpredictionof progressionfree survival inconventional
TACE or TACE withdrug-elutingbeadsinHCC”
Promoter: Prof. Dr. VincentVandecaveye
2010-2011 Medical Lab Technician Courses (MLT), University Hospitals Leuven
2011 Concepts in Clinical Research (Begrippen in Klinisch onderzoek), University Hospitals Leuven
(38.4 hour course with final examination)
2011 International Reference sitecommunicationtraining, CustomerVisitCenter–Philips
Healthcare Best,The Netherlands(2-daycourse)
2013 MR physicscourse,Philips,Brussels(4x 3h eveningcourse)
2013 GCPtrainingcourse:Interactive GCP-workshopforexperiencedresearchers:The EUclinical trial
directiveanditsimplicationsonyourclinical researchpractice,UniversityHospitalsLeuven
H O N O R S A N D G R A N T S
2012 Travel Grant ‘Academische StichtingLeuven’ (ASL)
Travel Grant ‘FondsWetenschappelijkOnderzoek(FWO)’- Vlaanderen
2012 Firstprize forbestoral presentation:“Whole-bodydiffusion-weightedMRIfornon-invasive
staginginpatientswithovariancancer”International CancerImagingSociety(ICIS) 2012,
Oxford,UK
2014 Firstprize forbestoral presentation:“Whole-bodydiffusion-weightedMRIversusCTfor
detection,restagingandoperabilityassessmentof recurrentovariancarcinoma”
International CancerImagingSociety(ICIS) 2014, Heidelberg,Germany

3. CurriculumVitae KatrijnMichielsen
L A N G U A G E S
Dutch Native language
English Fluentlywrittenandspoken
French Basic knowledge
V A R I O U S C O M P E T E N CE S
Computerskills
- Windows,Word,Outlook,Excel,Powerpoint,Access
- IBM SPSSSoftware,Statistica
- Clinical workstation(JavaKWS)
- Picture ArchivingandCommunicationSystem(PACS)
Lab skills
- Workingwithanimal models
Interpersonal skills
- Teamwork
- Verbal communication
- Responsibility
- Publicspeaking
- Problemsolving
- Networking
- Motivation
- Flexibility
- Conflictresolution
Hobbies
- Singing
- Reading
- Meeting friends
- Wine tasting
- Running
Driver’s License type B

4. CurriculumVitae KatrijnMichielsen
S T UD E NT J O B S
2003 JanssenPharmaceutica,Beerse
Title:studentjob
Function:Office Administrator
2004-2010 Cash FreshVosselaar(ADDelhaize since 2009)
Title:studentjob
Function:collaboratorbutcher
2007-2009 Lavetan, Turnhout
Title:studentjob
Function:LaboratoryworkerMicrobiology

5. CurriculumVitae KatrijnMichielsen
S C I E N T I F I C P U B L I C A T I ON S I N I N T E R N A T I O N A L L Y P E E R R E V I E W E D J O U R N A L S
- Fetal cerebral bloodflow velocitiesincongenitaldiaphragmatichernia.VanMieghemT,Sandaite
I, MichielsenK,GucciardoL, Done E, DekoninckP,ClausF,DeprestJ.UltrasoundObstetGynecol.2010
Oct;36(4):452-7.
- MR volumetryof the normal fetal kidney:referencevalues.MichielsenK, MeersschaertJ,De Keyzer
F, Cannie M, DeprestJ,ClausF. PrenatDiagn.2010 Nov;30(11):1044-8.
- Prenatal anatomical imaginginfetuseswithcongenitaldiaphragmatichernia.ClausF, Sandaite I,
DeKoninckP,MorenoO, Cruz MartinezR, VanMieghemT, Gucciardo L, RichterJ, MichielsenK,
Decraene J, Devlieger R, Gratacos E,Deprest JA. Fetal Diagn Ther. 2011;29(1):88-100.
- Whole-bodyMRIwithdiffusion-weightedsequenceforstagingof patientswithsuspectedovarian
cancer:a clinical feasibilitystudyincomparisontoCTandFDG-PET/CT.MichielsenK,Vergote I,Opde
BeeckK,AmantF, LeunenK, MoermanP,Deroose C,SouverijnsG, DymarkowskiS, De Keyzer
F, Vandecaveye V.EurRadiol.2014 Apr;24(4):889-901.
- Chemoembolizationforhepatocellularcarcinoma:1-monthresponse determinedwithapparent
diffusioncoefficientisanindependentpredictorof outcome.Vandecaveye V, MichielsenK, De Keyzer
F, LalemanW, KomutaM, Op de beeckK,RoskamsT, NevensF, Verslype C,Maleux G.Radiology.2014
Mar;270(3):747-57.

6. CurriculumVitae KatrijnMichielsen
A B S T R A C T S O N N A T I O N A L A N D I N T E R N A T I O NA L S C I E N T I FI C M E E T I N G S
- Pretreatment dynamic contrast-enhanced magnetic resonance imaging predicts progression free
survival in hepatocellular carcinoma patients treated with chemo-embolization. C. Verslype, K.
Michielsen, F. De Keyzer, S. Dymarkowski, H. van Malenstein, R. Oyen, F. Nevens, G. Maleux, V.
Vandecaveye.
62nd Annual Meeting of the American Association for the Study of Liver Disease (AASLD), San
Francisco, USA,Nov2011. Oral presentation.
- Pretreatmentdynamiccontrast-enhancedmagneticresonance imagingforpredictionof progression
free survival intranscatheterarterial chemoembolizationordoxorubicinlipiodolizationwith
embolizationinhepatocellularcarcinoma. K.Michielsen,F.De Keyzer, C.Verslype,S.Dymarkowski,H.
van Malenstein,R.Oyen,G.Maleux,V.Vandecaveye.22ndAnnual MeetingandPostgraduateCourse,
EuropeanSocietyof GastrointestinalandAbdominal Radiology(ESGAR),Venice,Italy,May2011.
ePosterpresentation.
- PretreatmentDCE-MRIforpredictionof progressionfree survival intranscatheterarterial
chemoembolizationordoxorubicinlipiodolizationwithembolizationinHCC.K. Michielsen,F.De
Keyzer, C. Verslype,S.Dymarkowski,H.vanMalenstein,R.Oyen, G.Maleux,V.Vandecaveye.
Oncoforum2011, CatholicUniversityLeuven,Leuven,Belgium,May2011. Posterpresentation.
- PretreatmentDCE-MRIforpredictionof PFSinpatientswithinoperable HCCtreatedwithTACE.K.
Michielsen,F.De Keyzer, C.Verslype, S.Dymarkowski,H.vanMalenstein, G.Maleux,V.Vandecaveye.
SocietyMeeting&11th
Annual TeachingCourse,International CancerImagingSociety(ICIS),
Copenhagen,Denmark, October2011. Oral presentation.
- Clinical feasibility of whole-body diffusion-weighted MRI in the diagnosis of ovarian cancer. K.
Michielsen, MSc; N. Grauwen; F. De Keyzer, MSc; K. Leunen, MD; K. Op de beeck, MD; F. Amant, MD,
Phd; P. Moerman, MD, Phd; C. Deroose, MD, Phd; S. Dymarkowski, MD, Phd; I. Vergote, MD, Phd; V.
Vandecaveye, MD, Phd. Oncoforum2012, CatholicUniversityLeuven,Leuven,Belgium, May2012. Poster
+ oral presentation.

7. CurriculumVitae KatrijnMichielsen
- Whole-body diffusion-weighted MRI for non-invasive staging in patients with ovarian cancer. K.
Michielsen, MSc; I. Vergote, MD, PhD; F. De Keyzer,MSc; N. Grauwen, MMed; K. Leunen, MD, PhD; K.
Op de beeck, MD; F. Amant, MD, PhD; P. Moerman, MD, PhD; C. Deroose, MD, PhD; S. Dymarkowski,
MD, PhD; V. Vandecaveye, MD, PhD. International Cancer Imaging Society (ICIS) Meeting and 12th
Annual Teaching Course, Oxford, UK, October 2012. Oral presentation (first price oral presentation).
- Whole body diffusion-weighted MRI for non-invasive staging and operability assessment in patients
with ovarian cancer. K. Michielsen, MSc; V. Vandecaveye, MD, PhD; F. De Keyzer, MSc; N. Grauwen,
MMed; K. Leunen,MD,PhD;K. Opde beeck, MD; F. Amant,MD,PhD;P. Moerman, MD, PhD;C. Deroose,
MD, PhD; S. Dymarkowski, MD, PhD; I. Vergote, MD, PhD. International Gynecoligic Cancer
Society14th
Biennial Meeting(IGCS),Vancouver,Canada,October 2012. Oral presentation.
- Clinical feasibility of whole-body diffusion-weighted MRI in the diagnosis of ovarian cancer. K.
Michielsen, MSc; I. Vergote, MD, PhD; F. De Keyzer MSc; N. Grauwen; K. Leunen, MD; K. Op de beeck,
MD; F. Amant, MD, PhD; P. Moerman, MD, PhD; C. Deroose, MD, PhD; S. Dymarkowski, MD, PhD; V.
Vandecaveye, MD, PhD. Radiological Society of North America (RSNA) 98th
Annual Meeting, Chicago,
USA, Nov-Dec 2012. Oral presentation.
- Whole-bodydiffusion-weightedMRIfordetectionandevaluationof operabilityinrecurrentovarian
canceras comparedwithCT.K. Michielsen,MSc;I.Vergote, MD, PhD;K. Opde beeck, MD; F. Amant,
MD, PhD; K.Leunen,MD, PhD;S. Dymarkowski,MD,PhD;P.Moerman,MD, PhD; F.De Keyzer, MSc;V.
Vandecaveye, MD, PhD.EuropeanCongressof Radiology(ECR),Vienna,Austria,March2014. Poster
presentation.
- Whole-bodydiffusion-weightedMRIversusCTfor detection,restagingandoperabilityassessmentof
recurrentovariancarcinoma.K. Michielsen,MSc;I.Vergote, MD, PhD;K. Op de beeck, MD; F.Amant,
MD, PhD; K.Leunen,MD, PhD;S. Dymarkowski,MD,PhD;P.Moerman,MD, PhD; F.De Keyzer,MSc;V.
Vandecaveye, MD, PhD.International CancerImagingSociety(ICIS)Meetingand14th
Annual Teaching
Course,Heidelberg,Germany,October2014. Oral presentation(firstprice oral presentation).

8. CurriculumVitae KatrijnMichielsen
- The value of whole bodydiffusion-weightedMRIfordetection,restagingandevaluationof operabilityin
recurrentovariancarcinomaascomparedwithCT. K.Michielsen,MSc;I.Vergote,MD,PhD;K. Opde
beeck, MD; F.Amant,MD, PhD; K. Leunen,MD,PhD;S. Dymarkowski,MD,PhD;P.Moerman,MD, PhD;
F. De Keyzer, MSc;V. Vandecaveye,MD,PhD.Radiological Societyof NorthAmerica(RSNA) 100th
Annual
Meeting,Chicago,USA, Nov-Dec2014.Oral presentation.
- PretreatmentADChistogram-analysisatwhole bodydiffusion-weightedMRIpredictsdisease free
survival inovariancancer. K.Michielsen,MSc;I.Vergote,MD,PhD; F. Amant,MD, PhD; S.Dymarkowski,
MD, PhD;F. De Keyzer,Msc;V.Vandecaveye,MD,PhD. International CancerImagingSociety(ICIS)
Meetingand15th
Annual TeachingCourse,London,UK,October2015. Oral presentation.
- Tumourcharacterization,stagingandoperabilityassessmentinovariancarcinoma:whole body
diffusion-weightedMRIversusCT. K.Michielsen,MSc;I.Vergote,MD,PhD; R. Vanslembrouck,MD;E.
Mussen,MD; F.Amant,MD, PhD; K. Leunen,MD,PhD; P. Moerman,MD, PhD; S. Fieuws,PhD; F.De
Keyzer, MSc;G. Souverijns,MD;S. Dymarkowski,MD,PhD;V.Vandecaveye,MD,PhD.International
CancerImagingSociety(ICIS) Meetingand15th
Annual TeachingCourse,London,UK,October2015.
Posterpresentation.
- PretreatmentADChistogram-analysisatwhole bodydiffusion-weightedMRIpredictsdisease free
survival inovariancancer. K.Michielsen,MSc;I.Vergote,MD,PhD; F. Amant,MD, PhD; S.Dymarkowski,
MD, PhD;F. De Keyzer,Msc;V.Vandecaveye,MD,PhD.EuropeanCongressof Radiology(ECR) 2016,
Vienna,Austria,Mar2016. Electronicposterpresentation&teaserpresentation.
- Whole bodydiffusion-weightedMRIfor tumourcharacterization,stagingandpredictionomcomplete
resectioninovariancarcinoma:a comparisonwithCT. K.Michielsen,MSc;I.Vergote,MD,PhD; R.
Vanslembrouck,MD;E. Mussen,MD; F. Amant,MD, PhD; K.Leunen,MD,PhD;F. De Keyzer,Msc; G.
Souverijns,MD;V.Vandecaveye,MD,PhD.EuropeanCongressof Radiology(ECR) 2016, Vienna,
Austria,Mar 2016. Oral presentation&posterpresentation.